The dawn of Pharmaco-Genetics for AMD – Page 29 of 57

Macula Risk NXG includes 15 variants across 12 genes that represent all of the key biological pathways that have been associated and validated with AMD. This is the most comprehensive genetic test available. The CFH and ARMS2 alleles are most important in determining which supplement a specific patient should be consuming. The new Vita Risk test does this.